Research graph
References from A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa. Local targets link to admitted publications; unresolved targets remain external evidence.
Chapter 39 - Meningococcal capsular group A, C, W, and Y conjugate vaccines
2023 · External reference
Global epidemiology of meningococcal disease-causing serogroups before and after the COVID-19 pandemic: a narrative review
10.1007/s40121-024-01063-5 · 2024 · External reference
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT
10.1080/14760584.2021.1964962 · 2021 · External reference
Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review
10.1017/s0950268823000328 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
The epidemiology of meningococcal disease in India
10.1111/j.1365-3156.2010.02660.x · 2010 · External reference
A comprehensive review of meningococcal disease burden in India
10.1007/s40121-020-00323-4 · 2020 · External reference
Meningococcal disease burden in India: a systematic review and meta-analysis
10.1177/11786361211053344 · 2021 · External reference
An overview of meningococcal disease in India: knowledge gaps and potential solutions
10.1016/j.vaccine.2013.04.003 · 2013 · External reference
Molecular detection and serotyping of acute bacterial meningitis pathogens in Indian children
10.1007/s10096-025-05198-2 · 2025 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Meningococcal meningitis in India: an expert consensus on use of MCVs
10.1080/21645515.2026.2676385 · 2026 · External reference
Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
10.1080/21645515.2022.2026712 · 2022 · External reference
Unresolved reference
External reference
Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020
10.1016/j.ijid.2022.07.068 · 2022 · External reference
Unresolved reference
External reference
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT
10.1080/14760584.2021.1964962 · 2021 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine in healthy meningococcal-naïve children 2-9 years of age: a phase III, randomized study
10.1097/inf.0000000000002832 · 2020 · External reference
A phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States
10.1016/j.vaccine.2020.03.017 · 2020 · External reference
Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: a phase III randomized study
10.1016/j.vaccine.2020.06.013 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine versus Nimenrix in healthy adolescents: a randomized phase IIIb multicenter study
10.1007/s40121-024-01009-x · 2024 · External reference
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)
10.1080/21645515.2025.2516949 · 2025 · External reference
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: a phase III randomized study
10.1016/j.vaccine.2020.04.067 · 2020 · External reference
Immunogenicity and safety of quadrivalent meningococcal conjugate vaccine (MenACYW-TT) in potential hajj/Umrah pilgrims aged≥56 years: a phase III, open-label study
10.1007/s40121-025-01298-w · 2026 · External reference
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a phase II randomized study
10.1080/21645515.2020.1733869 · 2020 · External reference
Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context
10.1080/21645515.2020.1871572 · 2021 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides
10.1016/s0008-6215(00)90802-4 · 1988 · External reference
Risk of group a meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora
10.1128/jcm.22.2.152-156.1985 · 1985 · External reference
Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis
10.1111/j.1574-695x.2002.tb00597.x · 2002 · External reference
Epidemiology and pathogenesis of Neisseria meningitidis
10.1016/s1286-4579(00)00356-7 · 2000 · External reference
Unresolved reference
External reference
